>

Amgen News Timeline Breakdown

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 40px;;'>AMG</div>
AMGN -- USA Stock  

Fiscal Quarter End: March 31, 2020  

This is yet another view into Amgen filtered headlines to help investors concentrate on Amgen noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Amgen headlines in addition to utilizing other more conventional financial analysis modules. Please continue to Amgen Backtesting and Amgen Hype Analysis.
January 7, 2020
Amgen exotic insider transaction detected at MacroaxisInsider 
View Story
January 14, 2020
Acquisition by Frank Herringer of 1706 shares of Amgen subject to Rule 16b-3 at MacroaxisInsider 
View Story
January 17, 2020
Sale by Sharer Kevin W of 1000 shares of Amgen at MacroaxisInsider 
View Story
January 20, 2020
Sale by Nanula Richard D of 10000 shares of Amgen at MacroaxisInsider 
View Story
January 27, 2020
Sale by Sharer Kevin W of 2350 shares of Amgen at MacroaxisInsider 
View Story
January 30, 2020
Sale by Sharer Kevin W of 198 shares of Amgen at MacroaxisInsider 
View Story
February 4, 2020
Acquisition by Charles Holley of tradable shares of Amgen subject to Rule 16b-3 at nasdaqnewsupdates.com 
View Story
February 7, 2020
Sale by David Piacquad of 9264 shares of Amgen at nasdaqnewsupdates.com 
View Story
February 11, 2020
Payment of 462 shares by Lori Johnston of Amgen subject to Rule 16b-3 at MacroaxisInsider 
View Story
February 14, 2020
Bona fide gift to Fenton Dennis M of 3617 shares of Amgen subject to Section 16 at MacroaxisInsider 
View Story